Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
QUINCE THERAPEUTICS <QNCX.O>: LEERINK PARTNERS ADJUSTS TARGET PRICE TO $68 FROM $4 TO REFLECT 1-FOR-20 REVERSE STOCK SPLIT

QUINCE THERAPEUTICS <QNCX.O>: LEERINK PARTNERS ADJUSTS TARGET PRICE TO $68 FROM $4 TO REFLECT 1-FOR-20 REVERSE STOCK SPLIT

ReutersReuters2026/08/18 10:53
By:Reuters
QUINCE THERAPEUTICS
: LEERINK PARTNERS ADJUSTS TARGET PRICE TO $68 FROM $4 TO REFLECT 1-FOR-20 REVERSE STOCK SPLIT
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!